EFXT Q1 2026 Earnings Earnings Surge Past Estimates by 65 GOOD Q1 2026 Earnings Strong EPS Beat Despite Negative Market Reaction Editas Medicine Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment CIMP Q1 2026 Earnings EPS Surpasses Estimates as Company Demonstrates Resilient Performance FNB Q1 2026 Earnings Slight EPS Miss as Stock Edges Lower Vaxcyte PCVX Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline